<SEC-DOCUMENT>0001493152-23-029891.txt : 20230823
<SEC-HEADER>0001493152-23-029891.hdr.sgml : 20230823
<ACCEPTANCE-DATETIME>20230823085104
ACCESSION NUMBER:		0001493152-23-029891
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230823
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230823
DATE AS OF CHANGE:		20230823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AIM ImmunoTech Inc.
		CENTRAL INDEX KEY:			0000946644
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				520845822
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-27072
		FILM NUMBER:		231195362

	BUSINESS ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801
		BUSINESS PHONE:		352-448-7797

	MAIL ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEMISPHERX BIOPHARMA INC
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:aim="http://aimimmuno.com/20230823">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_aim_aimimmuno.com_20230823 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230823_20230823 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000946644 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityCentralIndexKey">0000946644</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aim-20230823.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-08-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000946644</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-23</xbrli:startDate>
        <xbrli:endDate>2023-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"></p>

<p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"></p>

<p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt; color: Black"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><b>FORM
<span id="xdx_907_edei--DocumentType_c20230823__20230823_zxwtQQBpTvs2"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CURRENT
REPORT</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Date
of Report: <span id="xdx_900_edei--DocumentPeriodEndDate_c20230823__20230823_zBBX1bcN6W0k"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 23, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><b><span id="xdx_905_edei--EntityRegistrantName_c20230823__20230823_zzG4bA87ON26"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityRegistrantName">AIM
IMMUNOTECH INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230823__20230823_z6CX2CxeSP16"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_90D_edei--EntityFileNumber_c20230823__20230823_zAAwoYgN4Vzh"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityFileNumber">001-27072</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20230823__20230823_zJUNi70KdVRj"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityTaxIdentificationNumber">52-0845822</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(state or
    other jurisdiction</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(Commission</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(I.R.S. Employer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">of incorporation)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">File Number)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Identification
    No.)</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span id="xdx_909_edei--EntityAddressAddressLine1_c20230823__20230823_zZOYh2QXjd23" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityAddressAddressLine1">2117
    SW Highway 484</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_90E_edei--EntityAddressCityOrTown_c20230823__20230823_zAumn2D2EDu"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityAddressCityOrTown">Ocala</ix:nonNumeric>
    </span></span></b><b><span id="xdx_907_edei--EntityAddressStateOrProvince_c20230823__20230823_z2ervaPxnVV" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span id="xdx_905_edei--EntityAddressPostalZipCode_c20230823__20230823_z10jd0WhgNyi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:EntityAddressPostalZipCode">34473</ix:nonNumeric></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(Address of
    principal executive offices)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(Zip Code)</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt">Registrant&#8217;s
telephone number, including area code: <b>(<span id="xdx_906_edei--CityAreaCode_c20230823__20230823_zx4c8tLE3HIj"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:CityAreaCode">352</ix:nonNumeric></span></b><b>)
<span id="xdx_900_edei--LocalPhoneNumber_c20230823__20230823_ztrMPsmGBDqd"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:LocalPhoneNumber">448-7797</ix:nonNumeric></span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_90A_edei--WrittenCommunications_c20230823__20230823_zfgUR265huC3"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_908_edei--SolicitingMaterial_c20230823__20230823_z9vopQ5Z2jR4"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_901_edei--PreCommencementTenderOffer_c20230823__20230823_zVHvgoRhciO"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20230823__20230823_z17r9Jakij58"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Emerging
growth company <b><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20230823__20230823_z0Q2VVlrKzni"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <b>&#9744;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; background-color: white; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; text-indent: 27.8pt; background-color: white; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Title
    of each class</span></td>
    <td style="vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Trading
    Symbol</span></td>
    <td style="vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Name
    of each exchange on which registered</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_902_edei--Security12bTitle_c20230823__20230823_zHkSXrFIIms1"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_90C_edei--TradingSymbol_c20230823__20230823_zKo1qdvTH0If"><ix:nonNumeric contextRef="AsOf2023-08-23" name="dei:TradingSymbol">AIM</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_90F_edei--SecurityExchangeName_c20230823__20230823_zMZBmwtDqSv7"><ix:nonNumeric contextRef="AsOf2023-08-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span style="text-decoration: underline">Item
7.01. Regulation FD Disclosure.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On
August 3, 2023, Ted D. Kellner submitted to AIM ImmunoTech Inc. (the &#8220;Company&#8221;) a purported notice (the &#8220;Notice&#8221;),
dated August 4, 2023, seeking to nominate three candidates to stand for election to the Company&#8217;s Board of Directors (the &#8220;Board&#8221;)
at the Company&#8217;s 2023 annual meeting of stockholders (the &#8220;2023 Annual Meeting&#8221;). The Board has reviewed the Notice
and determined that it fails to comply with applicable requirements for making director nominations that are set forth in the Company&#8217;s
bylaws. On August 23, 2023, the Company&#8217;s outside legal counsel sent a letter (the &#8220;Letter&#8221;) to Mr. Kellner&#8217;s
outside counsel on behalf of the Company stating that the Notice does not constitute a valid notice of director nominations for the 2023
Annual Meeting, and as the deadline for providing a timely and proper notice of nominations at the 2023 Annual Meeting has passed, any
nominations that purport to be made pursuant to the Notice will be disregarded. A copy of the Letter is furnished as Exhibit 99.1 to
this Report.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On
August 23, 2023, the Company issued a press release announcing that the Notice is invalid. A copy of the press release is furnished as
Exhibit 99.2 to this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
information contained in Item 7.01 to this Report and Exhibits 99.1 and 99.2 attached hereto is &#8220;furnished&#8221; and shall not
be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange
Act or the Securities Act of 1933, as amended, if and to the extent such subsequent filing specifically references the information herein
as being incorporated by reference in such filing.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(d)
Exhibits.</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
    No.</b></span></td>
    <td style="vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter, dated August 23, 2023</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Press Release, dated August 23,
    2023</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the
    Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>SIGNATURES</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">AIM IMMUNOTECH INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">August
    23, 2023</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i>/s/
    Thomas K. Equels</i></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Thomas K. Equels, CEO</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-indent: 0.25in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></p>

<p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk1TBO2jRUWsIkXE12C3EmyzZZP6cyRvaWwRl4VlmflmhBiJNa1MjQznRZHDEZu21h6hwAoZ7QWDI9tsUwi3wKtxnrX1/fsDMwoMBmY6juc6CL31bhyWKcjZRKmJSkDGqUzgsBPRV8/IVqZE642uQdsSDkwtG/SaX0PCUT/JUvPqq07IzpBNIR7LQX6DkrGCPd31g/jmIM8zEY36icSaqWu/NZ3z1MCyxiZ0uQH9b/QBGatJSw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exhibit
99.1</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="font: 12pt Times New Roman, Times, Serif; width: 50%"><IMG SRC="ex99-1.jpg" ALT=""></TD>
    <TD STYLE="text-align: right; font: 12pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 10pt">1313 North Market Street</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">P.O. Box 951</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Wilmington, DE 19801- 0951</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">302 984 6000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">www.potteranderson.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Michael
    A. Pittenger</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpittenger@potteranderson.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">302
    984-6136 Direct Phone</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">302
    778-6136 Fax</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
23, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
E-MAIL AND FEDEX</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
J. Harrington</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baker
&amp; Hostetler LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
Tower, Suite 2000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">127
Public Square</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cleveland,
Ohio 44114-1214</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AIM
    ImmunoTech Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Response
    to Purported Notice of Stockholder Intent to Nominate Individuals for Election as Director at the 2023 Annual Meeting of Stockholders
    of AIM ImmunoTech Inc.</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Harrington:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of my client, AIM ImmunoTech Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo; or &ldquo;<B><I>AIM</I></B>&rdquo;),
I am writing in response to the letter from Ted D. Kellner, dated as of August 4, 2023 (the &ldquo;<B><I>Notice</I></B>&rdquo;), purporting
to serve as notice to the Company of Mr. Kellner&rsquo;s intent to nominate himself, Todd Deutsch and Robert L. Chioini as nominees to
be elected to the Company&rsquo;s board of directors (the &ldquo;<B><I>Board</I></B>&rdquo;) at the Company&rsquo;s 2023 annual meeting
of stockholders (the &ldquo;<B><I>2023 Annual Meeting</I></B>&rdquo;). Capitalized terms used but not otherwise defined herein shall
have the meanings ascribed to such terms in the Bylaws (as defined below) or, as applicable, the Company&rsquo;s Directors and Officers
Questionnaire in the form furnished to Mr. Kellner on July 31, 2023 (the &ldquo;<B><I>Questionnaire</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4 of the Company&rsquo;s Restated and Amended Bylaws (the &ldquo;<B><I>Bylaws</I></B>&rdquo; and such Section 1.4, the &ldquo;<B><I>Advance
Notice Bylaw</I></B>&rdquo;) sets forth the requirements for nominating persons for election to the Board at a duly held meeting of stockholders
of the Company. No stockholder may nominate persons for election to the Board absent compliance with such provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in detail in this letter, the Notice does not satisfy the requirements of the Advance Notice Bylaw in numerous respects. Among
other things, the Notice fails to describe certain agreements, arrangements and understandings (&ldquo;<B><I>AAUs</I></B>&rdquo;) accurately
and completely &ndash; or omits disclosure of AAUs &ndash; required to be disclosed and described under the Advance Notice Bylaws with
respect to the purported nominations and the attempted nominations in 2022. In addition, the Notice omits information or includes materially
false information regarding nominee qualifications and experience and in numerous cases fails to provide material information required
by the Advance Notice Bylaw, including, without limitation, regarding certain Stockholder Associated Persons, ownership information,
dates of first contact with Stockholder Nominees, line-item requirements under the federal proxy rules, and Schedule 13D information
regarding Stockholder Associated Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I. <I>The
Notice Fails to Provide a Complete and Accurate Description of All Agreements, Arrangements or Understandings Required to be Disclosed
Under the Advance Notice Bylaw </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice fails to provide a complete and accurate description of all AAUs with respect to Mr. Kellner&rsquo;s purported nominations and
the Company (or prior efforts to nominate) that are required to be disclosed under the Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(D) of the Bylaws requires that the Notice include &ldquo;a complete and accurate description of all agreements, arrangements
or understandings (whether written or oral, and including promises) between or among any two or more of any Holder, any Stockholder Associated
Person (as such terms &lsquo;Holder&rsquo; and &lsquo;Stockholder Associated Person&rsquo; are defined in this Section 1.4), any Stockholder
Nominee, any immediate family member of such Stockholder Nominee, any Affiliate or Associate of such Stockholder Nominee, any person
or entity acting in concert with any of the foregoing persons or entities with respect to the nominations or the Corporation (including
the full legal name (and any alias names) of any such person or entity acting in concert), and/or any other person or entity (including
the full legal name (and any alias names) of any such person or entity), existing presently or existing during the prior twenty-four
(24) months relating to or in connection with the nomination of any Stockholder Nominee or any other person or persons for election or
re-election as a director of the Corporation, or pursuant to which any such nomination or nominations are being made, or relating to
or in connection with the funding or financing of any nomination or nominations of any person or persons (including, without limitation,
any Stockholder Nominee) for election or re-election to the Board of Directors, including, without limitation, the funding or financing
of any proxy solicitation or litigation relating to such nomination or nominations&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(E) of the Bylaws requires that the Notice include &ldquo;(i) a complete and accurate description of all agreements, arrangements
or understandings (whether written or oral, and including promises) between or among each Holder and/or any Stockholder Associated Person
(as such terms &lsquo;Holder&rsquo; and &lsquo;Stockholder Associated Person&rsquo; are defined in this Section 1.4), on the one hand,
and any Stockholder Nominee, on the other hand, (x) to consult or advise on any investment or potential investment in a publicly listed
company (including the Corporation), and/or (y) to nominate, submit, or otherwise recommend the Stockholder Nominee for appointment,
election or re-election (or, for the avoidance of doubt, as a candidate for appointment, election or re-election) to any officer, executive
officer or director role of any publicly listed company (including the Corporation), in each case, during the past ten (10) years; and
(ii) a complete and accurate description of the outcome of any situations described pursuant to the foregoing clause (i)&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(J) of the Bylaws requires that the Notice include &ldquo;a complete and accurate description of all direct and indirect compensation
and other monetary or non-monetary agreements, arrangements or understandings (whether written or oral) existing presently, that existed
during the past three (3) years or that were offered during the past three (3) years (whether accepted or declined), and any other material
relationships, between or among any Holder or any Stockholder Associated Person, on the one hand, and the Stockholder Nominee, any member
of the immediate family of such Stockholder Nominee, and/or the Stockholder Nominee&rsquo;s respective Affiliates and Associates, on
the other hand (including the full legal names (and any alias names) of such persons) and all biographical, related party transaction
and other information that would be required to be disclosed pursuant to the federal and state securities laws, including Rule 404 promulgated
under Regulation S-K (&lsquo;Regulation S-K&rsquo;) under the Securities Act of 1933 (the &lsquo;Securities Act&rsquo;) (or any successor
provision), if any Holder or any Stockholder Associated Person were the &lsquo;registrant&rsquo; for purposes of such rule and such Stockholder
Nominee were a director or executive officer of such registrant.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(i)(6) of the Bylaws defines &ldquo;Holder&rdquo; as &ldquo;the Noticing Stockholder [(<I>i.e.</I>, Mr. Kellner)] and each beneficial
owner [(<I>e.g.</I>, Mr. Deutsch)], if any, on whose behalf the nomination is made or other business is being proposed.&rdquo; Section
1.4(i)(8) defines &ldquo;Stockholder Associated Person,&rdquo; in relation to any Holder, as &ldquo;(i) any person acting in concert
with such Holder with respect to the Stockholder Proposal or the Corporation, (ii) any person controlling, controlled by, or under common
control with such Holder or any of their respective Affiliates and Associates, or a person acting in concert therewith with respect to
the Stockholder Proposal or the Corporation, and (iii) any member of the immediate family of such Holder or an Affiliate or Associate
of such Holder.&rdquo; It also defines the terms &ldquo;Affiliate&rdquo; and &ldquo;Associate&rdquo; as having the meanings attributed
to them under Rule 12b-2 of the Securities and Exchange Act of 1934 (as amended, the &ldquo;<B><I>Exchange Act</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>AAUs
Regarding the 2022 Annual Meeting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice omits disclosures and contains misleading and incomplete disclosures about Mr. Chioini&rsquo;s AAUs with several persons who acted
in concert with him (as well as with Messrs. Kellner and Deutsch) and who are Stockholder Associated Persons (<I>e.g.</I>, Jonathan Jorgl,
Franz Tudor, Michael Xirinachs, Paul Tusa, River Rock Advisors LLC (&ldquo;<B><I>River Rock</I></B>&rdquo;)) relating to Mr. Jorgl&rsquo;s
attempted nominations of Messrs. Chioini and Rice in 2022, and therefore fails to satisfy the requirements of Section 1.4(c)(1)(D), Section
1.4(c)(1)(E) and Section 1.4(c)(1)(J) of the Bylaws. As the Delaware Court of Chancery explained in its October 28, 2022 opinion denying
Mr. Jorgl&rsquo;s motion for a preliminary injunction, the discovery in the 2022 litigation confirmed that &ldquo;a web of individuals
had worked together to bring Jorgl&rsquo;s nomination forward.&rdquo; <I>Jorgl v. AIM ImmunoTech Inc.</I>, 2022 WL 16543834, at *1 (Del.
Ch. Oct. 28, 2022). Mr. Chioini had AAUs with Messrs. Jorgl, Tudor, Xirinachs, Tusa, and Mr. Tusa&rsquo;s entity River Rock, among others,
to, among other things, conceal the significant involvement of Messrs. Tudor and Xirinachs in the 2022 nomination efforts, including
(x) Mr. Tudor&rsquo;s significant role in initiating, planning,<SUP>1</SUP> and developing legal strategies for the nomination process,
selecting the nominees, searching for and identifying stockholders to be the &ldquo;face&rdquo; of the nominations, and otherwise coordinating
with Messrs. Chioini and Xirinachs in relation to the nomination efforts, and (y) Mr. Xirinachs&rsquo; significant role in planning and
developing legal strategies for the nomination process,<SUP>2</SUP> conspiring with Messrs. Chioini, Tudor, and Rice on plans for AIM
if the nominations were successful, promising to finance the nominations and related litigation, and holding out Mr. Tusa and River Rock
as the named funding source to conceal Mr. Xirinachs&rsquo; involvement and his funding commitment, even though there was never an intent
(or ability) for Mr. Tusa and River Rock to provide the financing. As the Court of Chancery found, &ldquo;it appears that Tudor and Xirinachs
were working with Chioini and others to devise legal strategies and formulate a plan for the proxy contest. They engaged in advance planning
towards a common end: to find an AIM stockholder who would transfer shares into record name and serve as the &lsquo;face&rsquo; of their
nomination. That stockholder was Jorgl.&rdquo; <I>Jorgl</I>, 2022 WL 16543834 at *13. The Court also explained that the actions of Mr.
Tudor and Mr. Xirinachs &ldquo;appear purposefully directed toward a shared goal of taking control of the Board.&rdquo; <I>Id</I>. The
conspirators also had an AAU to structure the enterprise to involve different cells of individuals, with only certain participants in
each cell communicating with participants in other cells, in a further effort to conceal the involvement of Messrs. Tudor, Xirinachs,
Kellner, Deutsch, and others in the nominations and to attempt to justify Mr. Jorgl&rsquo;s feigned ignorance of certain information
required to be disclosed in his nomination notice (the &ldquo;<B><I>Cell Structure AAU</I></B>&rdquo;). <I>See</I>, <I>e.g.</I>, <I>id</I>.
at *1 (&ldquo;a web of individuals had worked together to bring Jorgl&rsquo;s nomination forward.&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP><I>See</I>, <I>e.g.</I>, <I>id</I>. at *13 (&ldquo;Tudor launched the effort in the spring, leading to Lautz&rsquo;s nomination
of Chioini and Ring. When that failed, Tudor tried again. Chioini put Tudor in touch with Rice as a possible nominee, and Rice asked
Jorgl to become a stockholder and serve as the nominator. Tudor went dark around the time Jorgl entered the picture in late June, though
Kellner&rsquo;s contemporaneous notes the day after the Notice was submitted make clear that Tudor maintained some involvement.&rdquo;);
<I>id</I>. at *7 (&ldquo;Kellner&rsquo;s handwritten notes of the call state: &lsquo;Franz [Tudor] submitted 2 new directors on Friday
July 8th: 1. Mike Rice 2. Rob Chioini.&rsquo; Jorgl&rsquo;s nomination was not yet public.&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP><I>See</I>, <I>e.g.</I>, <I>id</I>. at *13 (&ldquo;Behind the scenes, Xirinachs was working with counsel and Chioini to put the
&lsquo;AIM process in[to] full swing.&rsquo;&rdquo;).</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of these AAUs are not mentioned or acknowledged at all in the Notice. As to those that are mentioned or alluded to, the Notice provides
information that is, at best, misleading. For example, it contains false and misleading statements about when Mr. Xirinachs first had
AAUs regarding the nominations with Messrs. Chioini, Tudor, and others, claiming he only reached an AAU with any other party shortly
after Mr. Jorgl submitted a nomination notice on July 8, 2022. However, Mr. Xirinachs had long been working with Messrs. Chioini and
Tudor (since at least April 2022) on the nomination conspiracy; Messrs. Xirinachs, Chioini, and Tudor had one or more AAUs in place regarding
the planned nominations well before July 8, 2022. These AAUs are evidenced by, among other things, the &ldquo;common interest&rdquo;
privilege that Messrs. Chioini and Xirinachs asserted in the 2022 litigation with respect to numerous pre-July 8 communications they
had with counsel to craft and plot the nomination process, including commenting on the draft Jorgl nomination notice. <I>Id.</I> at *13
n.152 (noting that Chioini&rsquo;s and Xirinachs&rsquo;s &ldquo;assertion of the common interest privilege implie[d] that the parties
.. . . were working together towards a shared objective&rdquo;). The Notice falsely portrays the nature, scope, and significance of Mr.
Xirinachs&rsquo; pre-July 8 role in the 2022 nomination process and omits the existence of Mr. Chioini&rsquo;s and Mr. Tudor&rsquo;s
pre-July 8 AAUs with him concerning the nominations. <I>Id</I>. at *7 (&ldquo;The extent and subject of these communications seem to
belie Jorgl&rsquo;s position that Xirinachs remained on the periphery through July 8.&rdquo;). The Notice also provides a knowingly
false narrative regarding AAUs concerning the funding of Mr. Jorgl&rsquo;s 2022 nominations, including untruthful statements concerning
the timing of Mr. Xirinachs&rsquo; commitment to fund the nominations (and related litigation) and a false narrative concerning the role
of Mr. Tusa and River Rock in funding the 2022 nominations. The Notice omits that the conspirators (including Messrs. Chioini and Xirinachs)
never truly intended that River Rock would be a funding source; rather, the plan all along was for Mr. Xirinachs to secretly channel
funds through River Rock in order to conceal his involvement and funding commitment, given that he had recently pled guilty to wire fraud
and had been found liable for securities law violations in a civil suit. The Notice also fails to acknowledge the Cell Structure AAU
among Mr. Chioini and other members of the conspiracy. Mr. Chioini was also involved in AAUs to avoid or postpone formalization of nomination-related
AAUs to conceal the involvement of participants in the conspiracy and to concoct a justification for Mr. Jorgl&rsquo;s feigned ignorance
of certain information required to be disclosed in his nomination notice. That too is not disclosed in the Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice also contains misleading and inaccurate disclosures about Mr. Chioini&rsquo;s AAUs with Messrs. Lautz, Tudor, and Daniel Ring
in 2022 relating to Lautz&rsquo;s failed nominations of Chioini and Ring and therefore fails to satisfy the requirements of Section 1.4(c)(1)(D),
Section 1.4(c)(1)(E) and Section 1.4(c)(1)(J) of the Bylaws. It intentionally downplays Mr. Chioini&rsquo;s role in that effort and omits
mention of any AAUs reached with Messrs. Tudor, Lautz, and Ring in connection with that effort.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice also omits and contains misleading and incomplete disclosures about Messrs. Deutsch&rsquo;s and Kellner&rsquo;s involvement in
the 2022 nominations and their AAUs with Mr. Tudor and other individuals acting in concert with them. This includes their AAUs with Mr.
Tudor to locate director candidates for the 2022 nominations, to identify a &ldquo;face&rdquo; to make the 2022 nominations (initially,
Mr. Lautz and ultimately, Mr. Jorgl), to structure a group of stockholders with aggregate ownership of more than 15% of AIM shares (by
Mr. Kellner&rsquo;s estimation) to support the dissident nominees, to spin out AIM&rsquo;s oncology business as a separate company if
Mr. Tudor&rsquo;s chosen nominees obtained control of the Board, and to knowingly participate in an enterprise structured to involve
different cells, as explained above, in order to evade detection of the full scope of their group, the identity of its participants,
and the involvement of felons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>AAUs
Regarding the 2023 Annual Meeting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice also fails to disclose AAUs reached in November or December 2022 among Messrs. Chioini, Rice, Kellner, and Deutsch regarding
their collective action and planning toward the shared goal of nominating persons for election to the Board in 2023 and it
inaccurately and misleadingly portrays the scope of their existing AAUs at that time, and therefore fails to satisfy the
requirements of Section 1.4(c)(1)(D), Section 1.4(c)(1)(E) and Section 1.4(c)(1)(J) of the Bylaws. These deficiencies are evidenced
by, among other things, communications by Baker &amp; Hostetler LLP (&ldquo;<B><I>BakerHostetler</I></B>&rdquo;) to AIM&rsquo;s
counsel in November and December, on behalf of BakerHostetler&rsquo;s clients Mr. Chioini and Mr. Rice. In November 2022,
BakerHostetler sent a letter to AIM advocating for the Board to appoint Mr. Chioini and Mr. Rice to the Board. In a follow up
discussion on December 5, 2022, again on behalf of Mr. Chioini and Mr. Rice, BakerHostetler stated that they would be amenable to
putting mutually agreeable directors on the AIM Board, but that they were &ldquo;impatient&rdquo; and if an agreement could not be
reached by the end of December, they would be &ldquo;better organized next year&rdquo; and were &ldquo;ready to come out guns
blazing.&rdquo; As Messrs. Chioini and Rice have both represented that they do not own any AIM stock, that threat could be made only
because Messrs. Chioini and Rice had one or more undisclosed AIM stockholders backing them or planning with them toward their shared
goal at the time. Messrs. Kellner and Deutsch are now represented by the same counsel who made those threats, and they, together
with Mr. Chioini, are carrying through with the threats. The Notice discloses that Messrs. Kellner and Deutsch were discussing
nominations with Mr. Chioini in late 2022, but fails to provide specific dates and is vague on the details. That timeframe
corresponds with the time that BakerHostetler was making the &ldquo;guns blazing&rdquo; threat and, likely not coincidently, is
shortly after Mr. Deutsch hired Mr. Tudor in October 2022. Yet the Notice not only fails to disclose any AAUs among Messrs. Kellner,
Deutsch, Chioini, Rice, and Tudor in late 2022, it falsely suggests Messrs. Kellner and Deutsch did not enter into any AAU with Mr.
Chioini regarding the 2023 nominations until July 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice also omits and contains false, misleading, and incomplete disclosures about Messrs. Kellner, Deutsch, and Chioini&rsquo;s AAUs
with each other and with their other collaborators, including Messrs. Xirinachs and Tudor, relating to the 2023 nominations, and therefore
fails to satisfy the requirements of Section 1.4(c)(1)(D), Section 1.4(c)(1)(E) and Section 1.4(c)(1)(J) of the Bylaws. Given that Mr.
Chioini owns no AIM stock but has nevertheless been planning with Messrs. Tudor and Xirinachs and others to take over AIM for well over
a year, it is not credible that he has no AAUs (and has had no such AAUs in the past 24 months) concerning an employment, advisory, or
consulting role with AIM or transactions involving AIM in the event the group obtains control of the Board. Moreover, Mr. Chioini is
already on the hook, jointly with Mr. Xirinachs, for approximately $2.0 million in expenses related to the 2022 nomination efforts at
AIM&mdash;with $1.3 million still outstanding&mdash;and has now agreed to bear a share of the potentially significant additional expenses
in connection with the 2023 nominations. As Mr. Chioini has represented that he does not own any AIM shares and the AIM non-employee
director compensation is set at $125,000/year, it strains the imagination to accept that Chioini is purely motivated by the promise of
a directorship at AIM and has no AAUs beyond seeking reimbursement of all 2022&ndash;23 expenses. Yet no such AAUs are disclosed in the
Notice. Equally not credible are the statements in the Notice contending that none of Messrs. Chioini, Kellner, or Rice has any ongoing
or new AAUs with Mr. Xirinachs regarding the 2023 nominations. This is implausible, particularly given Mr. Xirinachs significant role
in planning, funding, and developing legal strategies (along with Mr. Chioini and others) for the 2022 nominations and the commitment
of Messrs. Chioini, Kellner and Deutsch, if elected in conjunction with Mr. Kellner&rsquo;s attempted 2023 nominations, to seek to cause
AIM to reimburse the fees and expenses associated with Mr. Jorgl&rsquo;s failed 2022 nomination efforts and related litigation, for which
Messrs. Chioini and Xirinachs are both responsible. Likewise, the Notice&rsquo;s statement that there are no AAUs with Mr. Tudor &ldquo;with
regard to the instant nomination notice and related efforts&rdquo; is not credible, given Mr. Tudor&rsquo;s prominent role in initiating
and planning the 2022 nomination efforts, selecting the nominees, and coordinating with Messrs. Chioini, Deutsch, and Kellner, as well
as his current employment by Mr. Deutsch.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure by Mr. Kellner to provide truthful and full disclosure of the foregoing matters clearly fails to satisfy the requirements of
Section 1.4(c)(1)(D), Section 1.4(c)(1)(E) and Section 1.4(c)(1)(J) of the Bylaws and appears designed to mislead AIM&rsquo;s stockholders
and deprive them of information needed to make fully informed decisions should Messrs. Kellner, Deutsch, and Chioini stand for election.
An important purpose of advance notice bylaws, including the Advance Notice Bylaw, is to ensure that stockholders seeking to nominate
persons for election as directors cannot mislead their fellow stockholders in this manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II. <I>The
Notice Contains Materially False Information Regarding Nominee Qualifications and Experience and in Numerous Cases Fails to Provide Other
Material Information Required by the Advance Notice Bylaw </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Notice fails to satisfy the requirements of the Advance Notice Bylaw in numerous other ways, including, without limitation,
by providing materially false information regarding nominee qualifications and experience and in numerous cases failing to provide material
information required by the Advance Notice Bylaw.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Materially
False Information Regarding Nominee Qualifications</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(L) of the Bylaws requires that the Notice include among other information, a completed and signed Questionnaire from each Stockholder
Nominee. Section 1.4(c)(5) of the Bylaws requires a representation by the Noticing Stockholder as to the accuracy of the information
set forth in the Notice (and Mr. Kellner made such representation in the Notice). Question 1(g) of the Questionnaire is &ldquo;[i]f you
ever served on the board of directors of a publicly traded company, has any proxy advisory firm (including Institutional Shareholder
Services or Glass, Lewis &amp; Co. or their respective affiliates) issued an adverse recommendation regarding your candidacy as a director?
If yes, please identify the company, year and reasons for the adverse recommendation, to the extent known.&rdquo; Each of Messrs. Kellner,
Deutsch and Chioini checked &ldquo;No&rdquo; and provided no response to the &ldquo;If yes&rdquo; prompt. However, each of these responses
is categorically false. A basic search of recommendations presently available on the databases of Institutional Shareholder Services
(&ldquo;ISS&rdquo;) and Glass, Lewis &amp; Co. (&ldquo;Glass Lewis&rdquo;) reveals at least nine adverse recommendations with respect
to the three proposed nominees. With respect to Mr. Kellner, Glass Lewis recommended that stockholders &ldquo;withhold&rdquo; votes regarding
his re-election at the 2010 annual meeting of Marshall &amp; Ilsley Corporation (formerly NYSE: MI). Likewise, with respect to Mr. Deutsch,
ISS recommended that stockholders &ldquo;withhold&rdquo; votes regarding his re-election to the board of directors of Esquire Financial
Holdings, Inc. (Nasdaq: ESQ) in each of 2019 and 2022&mdash;the only years in which Mr. Deutsch has stood for re-election to ESQ&rsquo;s
board and where ISS has issued a related voting recommendation. Finally, with respect to Mr. Chioini, ISS recommended that stockholders
of Rockwell Medical, Inc. (Nasdaq: RMTI) &ldquo;withhold&rdquo; votes on his re-election in each of the last five annual meetings at
which he stood for re-election (i.e., at the 2003, 2006, 2009, 2012, and 2015 annual meetings); similarly, Glass Lewis recommended that
stockholders &ldquo;withhold&rdquo; on Mr. Chioini&rsquo;s re-election to the Rockwell Medical board in 2012. The fact that each of the
three proposed nominees concealed material information required to be truthfully disclosed in the Notice is (1) a clear and material
violation of the Advance Notice Bylaw, (2) constitutes, in each case, an independent basis to disqualify each of Messrs. Kellner, Deutsch
and Chioini as a proposed nominee, and (3) in each case, makes Mr. Kellner&rsquo;s representation as to the accuracy of the information
set forth in the Notice as required by Section 1.4(c)(5) of the Bylaws materially false. Moreover, while the Company was able to objectively
determine the falsity of these response based on a review of available ISS and Glass Lewis reports, these blatantly false disclosures
appear to be part of a pattern of false, misleading, or incomplete disclosures intended to mislead stockholders and raise the question
of what other information furnished in the Notice may be false or otherwise misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
Omission of Nominee Biographical Information</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(B) of the Bylaws requires for each Stockholder Nominee disclosure of &ldquo;a complete biography and statement of the
Stockholder Nominee&rsquo;s qualifications, including the principal occupation or employment of the Stockholder Nominee (at present
and for the past five (5) years).&rdquo; The Notice fails to satisfy this requirement with respect to Mr. Chioini as it fails to
describe Chioini&rsquo;s business experience&mdash;that is, his principal occupation or employment&mdash;during at least the time
period spanning from five years prior to the date of the Notice (August 4, 2018) through the founding of his consultancy business
Bright Rock Holdings, LLC at some point in 2019. This omission is particularly noteworthy in light of the contentious circumstances
of Mr. Chioini&rsquo;s departure from Rockwell Medical in 2018. The Notice fails to mention that Mr. Chioini was terminated by the
board of directors of Rockwell Medical and then reportedly refused to accept such determination and purportedly issued an
unsanctioned Form 8-K from Rockwell Medical with assertions about certain members of such board of directors.<SUP> 3</SUP>
Accordingly, an understanding of the nature of Mr. Chioini&rsquo;s principal occupation or employment during the intervening period
is highly material, and the omission of this material information both clearly fails to satisfy the requirements of the Advance
Notice Bylaw and also represents another example of false, misleading or incomplete disclosures intended to deceive
stockholders.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to Disclose Certain Stockholder Associated Persons</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(3)(A) of the Bylaws requires disclosure of &ldquo;the full legal name (and any alias names used) and address of each Holder .
.. . and the full legal name (and any alias names used) and address of each Stockholder Associated Person, if any.&rdquo; The Notice fails
to satisfy this requirement in a number of respects. First, the Notice fails to provide the full legal names of at least 10 family members
who are listed as &ldquo;Other Stockholder Associated Persons&rdquo; on Exhibit B of the Notice. Further, the Notice fails to disclose
the addresses and certain full names (and any alias names used) for Stockholder Associated Persons Tudor, Xirinachs, Tusa, River Rock,
and Looking Glass Capital Consultants Inc. While Mr. Kellner&rsquo;s family office is listed on Exhibit B, Mr. Deutsch does not list
the full name of his family office or explicitly state its address despite it appearing to be an Associate or Affiliate of his, and therefore,
a Stockholder Associated Person. Upon a cursory review of Form Ds and Form ADVs available on EDGAR, Mr. Kellner appears to own more than
10% of other entities that are not disclosed on Exhibit B as Stockholder Associated Persons. For example, Mr. Kellner appears to own
10% or more of entities such as Lakeview Equity Partners, LLC, FM Qualified Opportunity Fund LLC, and Coyote Fund, LLC. While it is possible
some of these entities may have been wound down or may no longer be affiliated with Mr. Kellner, we raise them to underscore that the
list of Stockholder Associated Persons is materially incomplete, and, to the extent there are Stockholder Associated Persons that are
not named, numerous other disclosures are rendered defective by not responding with respect to the appropriate set of Stockholder Associated
Persons.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3
</SUP>See &ldquo;Rockwell Medical Issues Statement,&rdquo; May 24, 2018, available from: <U>https://www.prnewswire.com/news-releases/rockwell-medical-issues-statement-300654699.html</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to Disclose Certain Ownership Information</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(3)(B) of the Bylaws requires disclosure of the Specified Information (as defined therein) with respect to the Holders, and Section
1.4(c)(1)(C) requires disclosure of the Specified Information with respect to each Stockholder Nominee and any member of such Stockholder
Nominee&rsquo;s immediate family or any person acting in concert with such Stockholder Nominee. The Notice purports to set forth responses
to some of the required items of Specified Information on pages 15&ndash;16 of the Notice&mdash;specifically, clauses (i), (viii), (ix)
and (xi) of Section 1.4(c)(3)(B)&mdash;but omits any affirmative or negative response to clauses (ii)&ndash;(vii) and (x) of Section
1.4(c)(3)(B) for each Holder and each Stockholder Nominees (and his immediate family members and any persons acting in concert with him).
We note that the Notice does not provide any indication as to how non-responses to a particular disclosure requirement should be treated.
Accordingly, by not responding to seven clauses for all of the Holders and Stockholder Nominees (and certain related persons), the Notice
fails to satisfy this requirement in an incalculable but certainly substantial number of ways. This deprives the Company and its Board
(and later, the other stockholders) from understanding whether any Holders, Stockholder Associated Persons or Stockholder Nominees (or
their immediate family members or other persons acting in concert), for example, (1) hold any short positions or other Derivative Instruments
with respect to the Company or (2) have any voting arrangements or Short Interests, any proportionate interests in the Company&rsquo;s
securities through any entities, or any contracts with any principal competitors of the Company. These omissions are particularly concerning
because, as just one example, the ownership of Derivative Instruments or Short Instruments could be used to profit at the same time that
a Holder or Stockholder Associated Person was disparaging the Company (<I>e.g.</I>, when Mr. Tudor was disparaging the Company and its
personnel on stock message boards).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to Disclose Dates of First Contact with Stockholder Nominees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(H) of the Bylaws requires, for each Stockholder Nominee, disclosure of &ldquo;the dates of first contact between any Holder
and/or Stockholder Associated Person, on the one hand, and the Stockholder Nominee, on the other hand, with respect to (i) the [Company]
and (ii) any proposed nomination or nominations of any person or persons (including, without limitation, any Stockholder Nominee) for
election or re-election to the Board of Directors.&rdquo; However, the disclosure set forth on page 11 of the Notice in apparent response
to this requirement plainly fails to satisfy this requirement as it does not provide the specific dates when each of the three Stockholder
Nominees first had contact with any Holder or Stockholder Associated Person with respect to the Company or any proposed nominations.
Instead of specific dates of first contact, the Notice merely provides generalizations, such as references to &ldquo;late 2021.&rdquo;
Through text messages, emails and/or call records, many of the dates of first contact would have been easily discernible, and yet there
is no responsive disclosure provided in respect to this requirement nor any effort to explain why specific dates of first contact could
not be discerned with any certainty in certain cases. We note that Mr. Chioini was proposed as a nominee on three occasions (first by
Lautz in April 2022, then by Mr. Jorgl in July 2022, and now by Mr. Kellner in August 2023), but the Notice fails to disclose any specific
date of first contact with any Holder and/or Stockholder Associated Person (which includes Messrs. Tudor, Xirinachs, Lautz, Tusa, and
others) for any of his proposed nominations (despite the fact that he purports not to be an AIM stockholder and a record holder of AIM
stock must necessarily be involved to make nominations). The Notice also fails to provide the dates of first contact among each Stockholder
Nominee and other Stockholder Associated Persons. For example, there is no disclosure describing when Messrs. Deutsch and Kellner first
were in contact with each other about proposing nominations for the Board (let alone for the 2023 Annual Meeting) or with respect to
the Company. The Notice also omits any disclosure regarding first contacts involving Messrs. Deutsch and Kellner with Stockholder Associated
Person Franz Tudor regarding the Company or Mr. Tudor&rsquo;s extensive efforts to nominate director candidates, including his roles
in the Lautz attempted nomination and the Jorgl attempted nomination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to Disclose Information Required by the Proxy Rules</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(1)(K) of the Bylaws requires a Noticing Stockholder to provide &ldquo;any other information relating to Stockholder Nominee that
would be required to be disclosed in a proxy statement or any other filings required to be made in connection with solicitations of proxies
for the election of directors in a contested election or that is otherwise required pursuant to and in accordance with Section 14 of
the Exchange Act, and the rules and regulations promulgated thereunder (including such Stockholder Nominee&rsquo;s written consent to
being named in proxy statements as a proposed nominee of the Noticing Stockholder and to serving as a director if elected).&rdquo; Further,
Section 1.4(c)(3)(E) of the Bylaws requires any other information relating to each Holder and each Stockholder Associated Person, if
any, that would be required to be disclosed in a proxy statement and form of proxy or other filings required to be made in connection
with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant
to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder. The Notice fails to satisfy these requirements
in numerous ways by failing to provide the information required by the following Items in Exchange Act Rule 14a-101 (&ldquo;<B><I>Schedule
14A</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stockholder
Nominee Consents</U>: The Stockholder Nominees each executed a nominee consent attached to the Notice as Exhibit A; however, the nominee
consents only include the consent of each Stockholder Nominee to &ldquo;being named as a nominee in any proxy statement filed by the
Nominating Stockholder . . .&rdquo; Thus, the nominee consents do not comply with Section 1.4(c)(1)(K) of the Bylaws, which requires
a Notice to include each &ldquo;Stockholder Nominee&rsquo;s written consent to being named in <B><I>proxy statement<U>s</U></I></B> as
a proposed nominee of the Noticing Stockholder&hellip;.&rdquo; (emphasis added) The consent requirement in Section 1.4(c)(1)(K) tracks
revisions to Rule 14a-4(d)(1)(i) made by the SEC in connection with the adoption of the universal proxy card rules (Rule 14a-19). As
part of the SEC&rsquo;s universal proxy rulemaking, Rule 14a-4(d)(1)(i) was revised to change the requirement that a nominee consent
to being named in &ldquo;the&rdquo; proxy statement of the party nominating the nominee&mdash;which is what the nominee consents in Exhibit
A do&mdash;to a more general requirement that a nominee consent to being named in &ldquo;a&rdquo; proxy statement, meaning the proxy
statements of any side in the proxy contest. This revision was necessary to facilitate the ability of every contestant in a proxy contest
to name all nominees, without regard to whom nominated them, on a universal proxy card. This defect is especially consequential not only
because it fails to satisfy the clear requirement of the Advance Notice Bylaw, but also because, if the Company were to determine it
is required to use a universal proxy card for the 2023 Annual Meeting, the Company does not have the consent of Messrs. Chioini, Deutsch
and Kellner to name them on its universal proxy card because of the deficient nominee consents included in the Notice do not give the
Company consent to name them in the Company&rsquo;s proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Item
4(b)(1)</U> requires a statement of the person by whom the solicitation is made and a description of the methods employed and to be employed
to solicit security holders. The Notice provides no response to this requirement. By failing to state who the participants (as defined
in Instruction 3 to Item 4 of Schedule 14A) in the Holders and/or Stockholder Associated Persons&rsquo; solicitation will be, the Notice
fails to respond to several other requirements under Schedule 14A or provides incomplete and misleading disclosure resulting in defective
responses to the requirements of the Advance Notice Bylaw. If accurate, the Notice could have simply included a statement about who the
Holders and/or Stockholder Associated Persons expected would be the participants in their solicitation or otherwise noted that the participants
were not yet all known. Instead, the Notice simply decided to ignore this requirement entirely, thereby omitting material information
required by the Advance Notice Bylaw.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Items
4(b)(2)&ndash;(3)(iii)</U> require disclosures about whether any regular employees or other participants are to be employed to solicit
security holders of the Company or any specially engaged employees, representatives or other persons have been or are to be employed
to solicit security holders of the Company. The Notice provides no response to this requirement. In connection with the 2022 solicitation,
Alliance Advisors, LLC was retained as a proxy solicitor for the Jorgl nominations, and the Notice states in a separate section that
&ldquo;[we] also expect to engage a proxy solicitor firm in connection with [our] efforts.&rdquo; However, in contravention of this requirement,
the Notice fails to disclose the anticipated cost of retaining such a proxy solicitor and certain other information relating to the solicitation
if a regular employee of any participant (<I>e.g.</I>, Mr. Deutsch&rsquo;s part-time employee Mr. Tudor) is to be employed in the solicitation
of proxies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Item
4(b)(4)</U> requires a statement of the total amount estimated to be spent and the total expenditures to date for, in furtherance of,
or in connection with the solicitation of security holders of the Company. The Notice omits this information, which is of particular
relevance for AIM stockholders and the Company considering Messrs. Kellner, Deutsch, and Chioini are seeking reimbursement not only for
all expenses related to their 2023 nominations but also for all expenses related to the 2022 Jorgl nominations and related litigation
(and do not intend to submit the question of such reimbursement to a vote the AIM stockholders).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Item
5(b)(1)</U> requires a description of any substantial interest, direct or indirect, by security holdings or otherwise, of each participant,
in any manner to be acted upon at the meeting, and is also required to include, with respect to each participant, the following information,
or a fair and accurate summary thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Item
5(b)(1)(i)</U> requires the name and business address of each participant. The Notice fails to name the expected participants in the
proxy solicitation, and therefore fails to satisfy the requirements of Item 5(b)(1)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Item
5(b)(1)(ii)</U> requires the participant&rsquo;s present principal occupation or employment and the name, principal business and address
of any corporation or other organization in which such employment is carried on. The Notice fails to name the expected participants in
the proxy solicitation, and therefore fails to satisfy the requirements of Item 5(b)(1)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Item
5(b)(1)(vii)</U> requires that if any part of the purchase price or market value of any of the shares purchased or sold within the past
two years by any participant is represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities,
the participant must disclose the amount of the indebtedness as of the latest practicable date. If such funds were borrowed or obtained
otherwise than pursuant to a margin account or bank loan in the regular course of business of a bank, broker or dealer, it also requires
a description of the transaction and the names of the parties. The Notice omits reference to these requirements in their entirety. To
the extent that the Stockholder Nominees, Holders, Stockholder Associated Persons or expected participants in their solicitation borrowed
or otherwise obtained funds to acquire or hold securities of the Company, the Notice fails to satisfy this disclosure requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Item
401(a) of Regulation S-K</U> requires certain information regarding any arrangement or understanding between the nominees and any other
person(s) (naming such person(s)) pursuant to which the nominee was or is to be selected as a director or nominee. The Notice fails to
satisfy this requirement for the reasons set forth in Part I of this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Failure
to Disclose Schedule 13D Information Regarding Stockholder Associated Persons</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(3)(D) of the Bylaws requires the disclosure of &ldquo;all information that would be required to be set forth in a Schedule 13D
filed pursuant to Rule 13d-1(a) or an amendment pursuant to Rule 13d-2(a) if such a statement were required to be filed under the Exchange
Act and the rules and regulations promulgated thereunder by each Holder and <B><I>each Stockholder Associated Person</I></B>, if any&rdquo;
(emphasis added). In response to this requirement, the Notice incorporates by reference that certain Schedule 13D filed by Messrs. Kellner
and Deutsch on July 27, 2023 (the &ldquo;<B><I>July 2023 13D</I></B>&rdquo;) in response to this requirement. However, this response
fails to satisfy the Advance Notice Bylaw, as the July 2023 13D fails to disclose information for each Stockholder Associated Person,
as required by the Advance Notice Bylaw, and this information is not otherwise included in the Notice. For example, the Notice fails
to disclose, for each other Stockholder Associated Person, among other things, the economic ownership (including certain derivatives)
of such person, the source of funds and, importantly, the purpose of the transactions underlying the Schedule 13D filing. These purposes
could include, among other things, extraordinary corporate transactions such as mergers, material asset divestitures or changes to the
composition of the Board. This information is critical for the Board and AIM stockholders to appropriately assess any nominations and
the interests and/or motives of those with whom they associate or have acted in concert in seeking a change in control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inaccurate
Certification Regarding Compliance with Legal Requirements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4(c)(3)(G) of the Bylaws requires &ldquo;a certification by the Noticing Stockholder that each Holder and any Stockholder Associated
Person has complied with all applicable federal, state and other legal requirements in connection with its acquisition of shares of capital
stock or other securities of the Company and/or such person&rsquo;s acts or omissions as a stockholder of the Company.&rdquo; The July
2023 13D discloses an incomplete account of the plans and proposals of the reporting persons Deutsch and Kellner and omits material information
about contracts, arrangements, understandings and relationships with respect to the securities of the Company. With respect to the foregoing,
Part I of this letter is hereby incorporated by reference. Further, the July 2023 13D omits plans and proposals related to fundamental
matters of corporate policy including, among other things, mergers and separations of material portions of the Company&rsquo;s underlying
business. The Holders&rsquo; prior and ongoing violations of Section 13(d) have not been remedied and other stockholders are likely to
be misled as to the intentions of the Holders. As the Company has detailed in its papers filed in the United States District Court for
the Middle District of Florida against Messrs. Tudor, Deutsch, Kellner, Jorgl, and Lautz and MCEF Capital LLC, including a complaint
filed on July 15, 2022, the Holders and certain Stockholder Associated Persons have violated the requirements of Section 13(d) of the
Exchange Act by failing to timely file (and amend) a non-misleading Schedule 13D (the &ldquo;Florida Litigation&rdquo;). On August 7,
2023, the Company filed a motion for the Court to reconsider its dismissal of the Florida Litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>*
* *</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each of the reasons set forth above, the Notice fails to satisfy the requirements set forth in the Advance Notice Bylaw. Accordingly,
the Notice does not constitute a valid notice of nominations for the 2023 Annual Meeting, and as the deadline for providing timely and
proper notice of nominations to be considered at the 2023 Annual Meeting has passed, any nominations that purport to be made pursuant
to the Notice will be disregarded and will not be considered at the 2023 Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expressly reserves any right or claim that it may have with respect to the Notice and the matter of nominations with respect
to the 2023 Annual Meeting. This letter should not be construed by any person as confirmation that the Notice otherwise complies with
the Bylaws or applicable law, including, without limitation, the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael A. Pittenger</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    A. Pittenger</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>cc</I>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    M. Seaman </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abrams
    &amp; Bayliss LLP</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Rodino, Chief Operating Officer, Executive Director for Governmental Relations, General Counsel, and Secretary</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AIM
    ImmunoTech Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    J. Mathew, P.C.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kirkland
    &amp; Ellis LLP</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exhibit
99.2</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AIM
ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Group
Seeking to Take Control of 75% of AIM Board Failed to Properly Disclose Myriad Interconnections, Understandings and Arrangements Among
Its Members &ndash; Violating the Company&rsquo;s Bylaws and Preventing Shareholders from Being Able to Make Fully Informed Decisions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Group&rsquo;s
Members  Include the Same Troubling Individuals Who Unsuccessfully Attempted to Take Over the AIM Board in 2022</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Campaign
Appears Partially Designed to Force AIM Shareholders to Foot the Bill for Activist Group&rsquo;s Millions of Dollars of Unpaid Expenses
from Unsuccessful 2022 Campaign</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Activist
Group Not Entitled to Nominate Board Candidates for AIM&rsquo;s 2023 Annual Meeting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OCALA,
Fla.</B>, August 23, 2023 &mdash; AIM ImmunoTech Inc. (NYSE American: AIM) (&ldquo;AIM&rdquo; or the &ldquo;Company&rdquo;) today announced
that, after careful deliberation, its Board of Directors (the &ldquo;Board&rdquo;) unanimously concluded that the notice (the &ldquo;Notice&rdquo;)
submitted by Ted D. Kellner purporting to nominate himself, Robert L. Chioini and Todd Deutsch for election to the Company&rsquo;s Board
at the 2023 Annual Meeting of Stockholders (the &ldquo;2023 Annual Meeting&rdquo;) fails to comply with the Company&rsquo;s Bylaws (the
&ldquo;Bylaws&rdquo;) and is invalid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of this conclusion, and given AIM&rsquo;s nomination deadline has passed, Kellner may not nominate any candidates for election
to the Board at the 2023 Annual Meeting. Accordingly, the Company will not recognize the nominations of Chioini, Deutsch and Kellner,
and any proxies submitted or votes cast for the election of these individuals will be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of AIM&rsquo;s letter to Kellner detailing the deficiencies in the Notice (the &ldquo;Deficiency Letter&rdquo;) will be filed with
the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) on Form 8-K today.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
2022 Activism Group Campaign</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
individuals referenced in Kellner&rsquo;s Notice &ndash; including Jonathan T. Jorgl, Walter I. Lautz, Michael Rice, Franz N. Tudor and
Michael J. Xirinachs &ndash; together with Chioini, Deutsch and Kellner (collectively, the &ldquo;Activist Group&rdquo; or the &ldquo;Group&rdquo;),
have been engaged in a multi-year effort to disrupt AIM&rsquo;s business and take over the Board. As a reminder, last year, the Group
&ndash; with Jorgl as the face of the effort &ndash; made a failed attempt to nominate a control slate of director candidates at the
Company&rsquo;s 2022 Annual Meeting of Stockholders (the &ldquo;2022 Annual Meeting&rdquo;). As was confirmed in litigation last year,
Tudor (and possibly other members of the Activist Group) even used &ldquo;burner&rdquo; accounts with fake names on retail stock message
boards to disparage the Company &ndash; apparently, in AIM&rsquo;s view, to drive down its stock price &ndash; while members of the Group
were trading AIM stock. The Group also attempted to conceal Tudor&rsquo;s and Xirinachs&rsquo; significant roles in orchestrating
the effort to gain control of AIM&rsquo;s Board. Tudor has been convicted of insider trading and Xirinachs has recently pled guilty to
wire fraud.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ahead
of the 2022 Annual Meeting, the Board unanimously determined that the Group&rsquo;s director nominations did not comply with AIM&rsquo;s
Bylaws and were invalid. After Jorgl, funded by Chioini and Xirinachs, initiated litigation contesting the Board&rsquo;s determination,
the Delaware Court of Chancery found in the Company&rsquo;s favor, denying Jorgl&rsquo;s motion to require the Board to accept his director
nominations. In its ruling, the Court noted that Jorgl failed to disclose arrangements and understandings among the &ldquo;web of individuals&rdquo;
behind the Group&rsquo;s efforts and stated that the evidence indicated that Jorgl&rsquo;s nomination notice &ldquo;was &ndash; at best
&ndash; misleading.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
2023 Activist Group Campaign</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bylaws exist for the protection of all shareholders. They require disclosures about nominating shareholders, director candidates and
related parties and arrangements so the Board can assess nominations and make voting recommendations based on complete, truthful information
&ndash; allowing shareholders to make well-informed choices about which nominees to support.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice fails to satisfy many of these requirements. As outlined in detail in the Deficiency Letter, among other items, the Notice omits
and misrepresents critical information about a range of interconnections between, and agreements, arrangements and understandings among,
members of the Activist Group. In addition, the Notice includes materially false information regarding the nominees&rsquo; qualifications
and experience, and fails to provide material information including with respect to related parties, ownership information, and other
items required under the federal proxy rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice&rsquo;s failures appear, in the Board&rsquo;s view, designed to mislead AIM&rsquo;s shareholders and deprive them of information
needed to make fully informed decisions. In addition, the Notice reveals that the Activist Group may have ulterior motives in their nominations
this year: Chioini and Xirinachs are jointly responsible for litigation costs stemming from their attempted proxy contest at the 2022
Annual Meeting and Jorgl&rsquo;s unsuccessful litigation and still owe the Group&rsquo;s law firm (in addition to certain other
advisors) a net amount of $1.3 million out of their $2 million bill, even as litigation expenses &ldquo;continue to accrue.&rdquo; The
Notice acknowledges that, if elected, Chioini will continue to seek reimbursement of his and Xirinachs&rsquo; expenses from 2022 &ndash;
likely over $2 million &ndash; <B><I>with AIM shareholders footing the bill</I></B>. The Notice also states that the Group would seek
reimbursement for its proxy fight efforts this time around as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
K. Equels, M.S., J.D., Executive Vice Chairman of the Board, CEO &amp; President, issued the following statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>It
is deeply troubling that this Activist Group is again seeking to benefit itself at the expense of other shareholders. This year&rsquo;s
Group is the same cast of characters who tried and failed to seize control of the Board at the 2022 Annual Meeting. Given the litany
of disturbing facts that came to light last year about its members, the Activist Group&rsquo;s attempt at a &ldquo;round two&rdquo; is
utterly perplexing. The Group&rsquo;s launching of another costly and distracting proxy contest demonstrates that they do not care about
the best interests of all shareholders.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Based
on the facts we have seen, we believe that the Activist Group is motivated by its desire to force the Company to reimburse its members
for expenses. Put another way, the Group is seemingly trying to gain control of the Board so it can force AIM shareholders to pick up
the entire multi-million-dollar tab for its unsuccessful 2022 proxy contest and litigation, as well as its 2023 campaign.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">###</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AIM
remains dedicated to delivering value for shareholders and to serving the patients for whom the Company is working to bring new therapies
to market to address a range of life-threatening cancers and debilitating immune disorders and viral conditions (including Long
COVID) &ndash; most notably by repurposing its lead drug, Ampligen. The Company is building on substantial momentum in recent years,
as well as its ability to accomplish the future clinical milestones it expects to achieve during the remainder of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
that end, AIM has a focused Board whose members possess the right mix of experience and expertise to effectively oversee the Company
and its strategy. In March 2023, the Company added Nancy Bryan as an additional independent director. Ms. Bryan is a pharmaceutical industry
veteran who brings deep commercial, marketing, business development and corporate finance expertise. She complements the strong and relevant
pharmaceutical, financial and legal experience of AIM&rsquo;s other directors. The Company continues to seek an additional independent
director who would add diverse and independent perspectives to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AIM
remains open to engaging constructively with all shareholders and values their input. The Company&rsquo;s recommended slate of nominees
for election to the Board at the Annual Meeting will be included in proxy materials to be filed with the SEC. Shareholders do not need
to take any action at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
AIM ImmunoTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AIM
ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers,
immune disorders and viral diseases, including COVID-19. The Company&rsquo;s lead product is a first-in-class investigational drug called
Ampligen&reg; (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials
for globally important cancers, viral diseases and disorders of the immune system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit aimimmuno.com and connect with the Company on Twitter, LinkedIn, and Facebook.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the &ldquo;PSLRA&rdquo;).
Words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate&rdquo; and similar expressions
(as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements.
Many of these forward-looking statements involve a number of risks and uncertainties. The Company urges investors to consider specifically
the various risk factors identified in its most recent Form 10-K, and any risk factors or cautionary statements included in any subsequent
Form 10-Q or Form 8-K, filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;). You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those
statements, the Company claims the protection of safe harbor for forward-looking statements contained in the PSLRA. The Company does
not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Important
Information</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to file with the SEC a proxy statement and associated <B>WHITE</B> proxy card in connection with the solicitation of
proxies for the Company&rsquo;s 2023 Annual Meeting. Details concerning the nominees of the Company&rsquo;s Board for election at the
2023 Annual Meeting will be included in the Company&rsquo;s proxy statement. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS
OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY&rsquo;S PROXY STATEMENT
AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
and stockholders will be able to obtain a copy of the Company&rsquo;s proxy statement, any amendments or supplements thereto and other
documents filed by the Company free of charge from the SEC&rsquo;s website, www.sec.gov. Copies of these materials will also be available
free of charge on AIM&rsquo;s Investor Relations website at https://aimimmuno.com/sec-filings/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Participants
in the Solicitation</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, its directors and certain of its executive officers will be participants in the solicitation of proxies from stockholders in
respect of the 2023 Annual Meeting. Information regarding the names of the Company&rsquo;s directors and executive officers and their
respective interests in the Company by security holdings or otherwise is set forth in the Company&rsquo;s Annual Report on Form 10-K
for the fiscal year ended December 31, 2022, filed with the SEC on March 31, 2023. To the extent holdings of such participants in the
Company&rsquo;s securities have changed since the amounts described in Form 10-K for the year ended December 31, 2022, such changes have
been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the
SEC. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the identity of
these participants in any proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise,
will also be included in any proxy statement and other relevant materials to be filed with the SEC by the Company, if and when they become
available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Contacts:</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JTC
Team, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jenene
Thomas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">833-475-8247</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AIM@jtcir.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Longacre
Square Partners</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joe
Germani / Dan Zacchei</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AIM@longacresquare.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1.jpg
<TEXT>
begin 644 ex99-1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ^ *8# 2(  A$! Q$!_\0
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MP%XBEUC2?$7PRM--G@\?>#-"\:V5K''K'B>RNQ<V%CKT5I?%HEB:ZMIFMW>
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MT+X6^)?">E:9-K/P?^)/[(OQ*_:T^(GAGXBVAUEK_1/&&G^+H/VK-:\&^*_
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M4A6WU &+4U:.T,AV1L)FV_JR1D8/3G]1C..F<<9],CO2% >PZYR1DYQC/NW
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MU?P%I5U_PA.L^%YM)T6U\4S_ +2M&K$''((.06!Z@]B/[H'.<+\OW3B@QH0
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-E%2MEZ??YEV_JY__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>aim-20230823.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayB2bP9z5Z8SekhvWB1bblKnywpqpGlsCG+0iVG4Y0K -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:aim="http://aimimmuno.com/20230823" elementFormDefault="qualified" targetNamespace="http://aimimmuno.com/20230823">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://aimimmuno.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="aim-20230823_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aim-20230823_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>aim-20230823_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>aim-20230823_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://aimimmuno.com/role/Cover" xlink:href="aim-20230823.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://aimimmuno.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140172971150704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-27072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AIM
IMMUNOTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000946644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-0845822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2117
    SW Highway 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ocala<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">34473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">448-7797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AIM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aim-20230823.xsd" xlink:type="simple"/>
    <context id="AsOf2023-08-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000946644</identifier>
        </entity>
        <period>
            <startDate>2023-08-23</startDate>
            <endDate>2023-08-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-08-23">0000946644</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-08-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-08-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-08-23">2023-08-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-08-23">AIM IMMUNOTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-08-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-08-23">001-27072</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-08-23">52-0845822</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-08-23">2117     SW Highway 484</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-08-23">Ocala</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-08-23">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-08-23">34473</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-08-23">352</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-08-23">448-7797</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-08-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-08-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-08-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-08-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-08-23">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2023-08-23">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-08-23">AIM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-08-23">NYSEAMER</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML>:'&T;AA; WP/65E.:C8;>MQ;\.@W\!4$L#!!0    ( &)&%U>?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( &)&%U<'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 8D875^G\
ME1SN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ 8D875YE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !B1A=7;LUAQE $  "!
M$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ 8D875Y^@&_"Q @  X@P   T              ( !DPP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !B1A=7EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aimimmuno.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>aim-20230823.xsd</File>
    <File>aim-20230823_lab.xml</File>
    <File>aim-20230823_pre.xml</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aim-20230823_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aim-20230823_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aim-20230823.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "aim",
   "nsuri": "http://aimimmuno.com/20230823",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://aimimmuno.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://aimimmuno.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-23-029891-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-029891-xbrl.zip
M4$L#!!0    ( &)&%U?[GK$F)@,  .,+   0    86EM+3(P,C,P.#(S+GAS
M9+56VW+:,!!][TS_0?5KQS:&)@T$DFG(),.$M)G07-J7CK 7T$26'$GFTJ^O
MY!L7 P':\B3MGG-V5]J5:9Y/0XK&("3AK&5Y3L5"P'P>$#9L60\]^TNOW>E8
MZ/SL_3ND?\T/MHVN"-"@@2ZY;W?8@)^BKSB$!KH&!@(K+D[1(Z:QL? K0D&@
M-@\C"@JT(XW40$>.5\?(MG?0?006</%PWRET1TI%LN&ZD\G$87R,)UR\2,?G
MX6Z"/855+ NURK22_7:CWQ+I%^3Z\6TD/T_OR?,0V$E\B=E$/N'91;5_5_]]
M]/.D!R^C\=.%U^_3&S:;1*_1-97MZX\5\GC]Z4?E)@W9E/X(0HST93#9LDQ]
M67F3FL/%T*U6*I[[?-OM)3@K!3:FE+"7=7"O7J^[B3>'EI#3OJ"Y=,TU[CZ6
M4"AK+]F")TPJS/PE?* *PB+XR$V=2U"R%GJ<0DD.#6 %)\%WAGSL:H?&5VLY
M,);V$..H  ^P[">BF6,)+(4J [5Q%62K601R+31U+1$P"0NH7I,PC!DW/9F@
M*B<&"11"8.J*B_ 2!CBF.I'7&%,R(!!82&$Q!&6:3$;8A[?D\E;%C''=T7JL
M,HNQ11'1+5L8M,E<<4-P"M]U[L@L]$AMB&&\;IOK=\%")&A9Z7)!+=<+8$ 8
M26)G,^0AVTQ,; K5RX39=%?!9:580O"-G27K2(#4]*2FKC9D_ RRG>MCZL?T
M(.H\OVW,S)Z?9.F(\U&ZAP%*1K!AFJ5E26(>02NSC00,6I8^=3N_SU^Z:D?W
M4HXP ;9,8')%JP>5Q<TEL/!+*J470HOP"(0BNJ$7GH$T<Z(,_6XA##)QI(7<
M?U<XQ?U]"]<4H/^QXJ[1+Y?:=)<'2^]7AZ^IJ^5"(58:XVVO:/K^=[F?2&VA
MF)V=\VQCLKVJ7?.<J0SFF>Z3Q/P$]DLBYQV0Q(:W?%U\N0EN%DD+[1ITPS=A
M:]"U'!>HDKGEX!06OR!_D4,BLU<22]<9*.$:"2-:M?4]UKS-Z;S%3/;RH";P
M><R4F.W3"(N4?'/8;<R__;M=1(Y/+\'\'3@T[ %=4 Z^K@6:;JJFEW\ 4$L#
M!!0    ( &)&%U<9TA87_0H  ("&   4    86EM+3(P,C,P.#(S7VQA8BYX
M;6S-G5UOX[@5AN\+]#]PW9L6&,?C!"V0[&07&4^R,#:;9&//;-M%L: EQA%"
MDP$E)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX__;C;4/1"1)IP=CZ:'GT<
M(<(B'B=L?3[ZNAA?+&;S^0BE&68QIIR1\Q'CHQ]_^/.?D/SSZ;OQ&%TEA,9G
MZ N/QG/VP+]'-WA#SM!/A!&!,RZ^1]\PW:HM_"JA1* 9WSQ3DA%94.SX#/W]
M:'J*T7@\H-YOA,5<?+V?5_4^9MES>C:9O+Z^'C'^@E^Y>$J/(KX95N$BP]DV
MK6K[N/M8_BG"/]&$/9VIOU8X)4@>+Y:>[=+D?*3V6^[V]>2(B_7D^./'Z>2?
MOUPOHD>RP>.$J>,6D9&.4K78XJ:GIZ>3O%1+6\K=2E"]CY.)ME/5+$N3#GW-
M29J<I;F]:Q[A+._VWMT@4*'^-]:RL=HTGAZ/3Z9'NS0>Z8.?'T'!*;DG#RAO
MYEFV?Y8HI8DB851N>Q3DP6Z&"C%1\1-&UC@CL=K1J=K1]!]J1W\I-U_C%:$C
MI)22#[!=IXVZRJ"):[-W1"0\OF3O<VU&>[(OOSLB^Q\:4(]WWH0ESS!]E_EZ
MI'/;-^1]1_P0Y_Y(RW&>O.](UR+_+[:SMN4W'U[[<:5JX[7\U+!(=IF<P$BL
M3:HJ.D;@? _YQ%#67=7.HT:]5(WF7+3;KF;&O,Z41$=K_C*)22+K/CY1'\;J
M0]YL^9\_9ERN!"Y6:29PE.F:\F:<CRSE$].24EX([0N+J*=QI6(2<3DU/6=C
M6AS&(OQ!\(UUMV6KN:7P#[JJXHO#(G<!&&W(!$GY5D3D3;U2=PL=I=+1ADJ%
M6E(1-OZZ&/V0:]#O6O6?3Y-#+0XZ6BZ!MAO"LJ6LT=*"9K&K;K:9TKU<+PNB
MDRV&S#[6$J0TCCOX0NXX5CN_HGAML6^4N^IBJRW=QXW"(#K9YLCLY4J#E,A7
M-W\A:2229[6<[VI'0^:\TRTF6WU?TX2%0-L83$)-ZVE@OR?K1$TMRH(ZOR5J
M8\<P!NA=#_V=MLVYP"H. IHA#L'9HAZ$JBA/'%TPML7TGCQST85/4^::&IM)
M$Y:Z)BA&+,9 - HM*L2>B/AU*\_8B:#[7BA:2M=< %9-- Q94'38O8& 5'*_
MC"P%9FFB!K!>2-I2YZ<;@-G6J8>A"XH3P!Q\2E+I_9*R>"24JOL!F/4/*#:Q
M:UI@PR8O;650Q(#V0&;R"%2&A(/-Y8M:G<METL#&UO0^X6G9[N*G$@>+D.EP
M($5Y&%)QGDBJW8;H8:BE=$T/8-7DQI %18S=&\A*(4>YWC\DERP>A$BE\P.(
M8=..1RD*$(ZFLSXTI-HG&%=)&F%:>+F2V]*.YEFTK@$![9J0M(1!@0*Y V$I
M C0S>8A78/Y%L!B&2TWI!Y:653LJE2Q 4$QO?9@HO1=(9ELA&J[A&0>6.KLI
MVV.VNC\+Z(( I<=<ZZYM(6^ XFD&NF19DNW5\W0WV\V*"$OCVA)7;$#F-!-F
M>1 L *9,!@H94CI4"+WTO+Y+P#+U$"/8'%/FE@"[R28%34U )%B- 30<M/DS
MI5Z(F,F126 Z9S'9_4SV8+M:.K=, #:;4!BB@*BP.P.P*,4H5R,I]P+&G4@V
M6.P72=0S5;2%;M& C#;9,%4!P0%8 ^@HU6@QG_F<299X-X\EJ,E#4CP/WD,)
MJ'<+2X_M)C. ."!TNAT"!,D@U(SR"=*<15P\\]KC#C.^E0/@?L9C>(72$^46
MJD%-:*+5&1(08$-\ I@U0C\4SZ0@KM[CR2M J@8OQ%W$L3Q0:?G/=<+(%&R_
M5>N6K@Z[3:8LPH!(@MT!_)3*#_H#4C'HEH4"S?$;FGKL'YKCH= <!PW-\7N@
M6;[R0* Y>4-33_Q#<S(4FI.@H3EY%S2RX[V.-3/Y\58L^:OMX6Q0Z069ME4K
M, =9>+BTO/7!H@+4>D:%^,0D7UC=BCO!7Q(6P4MF2.X%&,"TE1I#&QXZ=H-]
M_%0+8AWG=:PI%N6]7Q(M\S/*-$W:AYA"$QXD36.]@TNA]HG$'4\S3/^=/'>>
MB-O%7O"P&K9"TE"&AXK-7A\P10R203Y.K$M<U0T-ZZMD1KF[5X MM@ZO -<*
M@X# YJC]"G!Q]:00N>YFQ:@@&!@1FL7..MEBJNKC6ED87=PVU.KA_'LM-3Z^
MR"J["[U[Y Q^0* M<=73D#G=VV9Y$#T.F#)[/9>A7.?I:KS*,)':A^]:F;.9
MW;133>2Z((C>-=VTIFE=[K@W?Q-))O<\XYO-EI5W>6S/#0(Z5[W<:5/WN%44
M1.]W.3-)*+6H*7:,Q8+3)$JRA*U_D2>?(L&V5ME$KH" #6H:VHH@4 !MF1P<
MA$@K'4-P)XB"D,B.R%\"5(F%Q.W#@W6V[Q*[@J+?L(8#5@8!2:\]$Q89,(YJ
M$:@(07F,7VSF:;HEXDWP6$(\(02:!T!JZ4/$"3+9"U41Z).M!8FV<G[<3X]7
MRR2CMI/+ML39G 28JV8DHSP(-@!3)@MY&>(/:'K\U]7?D(YRW/TW?"FP2AZ[
MV&]6G +9IZPJ5Q!T6-0<6"1!H #[,FFXX:B4HD+K(SM5PZRE.4:Y*P"LMG37
M-PJ#Z'2;H]:7O]'7GH;\RUWT*$T1X(4$N\SUT&\S:0[_=4T0"'08:YV4E%*D
MM3Y>2#A,6>O^1<#:VR)@W;,(6(>X"%@/702LO2T"]&Z+%"%R7+I=T62-@>2$
MG6K74'18-OFP2(-"!?8'CAE5"#K$N,YHF:<X4^GYQ2;?_Y7\8&DEH'.6T[++
M9I74TB8*@I$N9ZVTED72N9H8*;5K+K9QDI&X,'.5,,RB!-,J/:+MBGA_B#-:
M!IJOP.G1A\'0,),MG(HPG<NP"CRDNG1]*;UX .,W0NG/C+^R!<$I9R0NKJ78
M[A1UZ]T^,=-CN_G0#" . J<A#H%'9U30^$E%(1U67@GS0M(W3K<LPR)_EUS8
M1B9 YY8<P&:3&$,4$"EV9P AE1@5:C\O:!?9(ZI%5O&[0V #(;GCU[4[31MO
M;5NU 3'3:1!ZA[O,^7%8&Q=1GEZQS(CZO8CDA7S!&2Z]@>V%Y*Y?JNPR;;Y-
M:=,&A%"G0?#]R2I&I8K!FBEO*6/$3"ZUUKSC*7%#Y3YQ3,MB.W=,)0D(#YNO
MC@PR FFM%Q86&TSIYVV:,)+"$Y&A<LN"U6*3A88D(!9LO@ 6<BG26B\L7&Z(
M6,OI[2?!7[/',C\KV#9 [9:-3LM-1JS2@%CI\@<PHT-0$:-3ZOJ!9W=(*%YD
M681;:I$ZQ@8T:S#3TH4$#&2N10LED;K><L,SM.3H:TI0]DC09?DS=/5,\$4]
MOGYI)(K4"Q'%JIS%6-@0ZA([_]41T'#KMT=:RB! ZK4'_PY)%8%TB&-J;B7#
MHGX>EYN89V0#ONW0'^**H*'F-4=]^B!H&FC29"H/:YY<YX%(1?K,9E1/;@\O
M\1HBQRMCBT%C85Q3!,$(: M:%M=_*\!/[KSMBB;1%>48OLK2T#C.F->V9R3+
M.P@"(J#M"DJ1EPM1KO32_Y\Q>Q+;YRS:WPD>$:*>LDJKT:KO^MO :+?,O*E)
M39H&A0;$V5O\ @0>JD"U.C[49BR?%_/40^,JFQN/GA:/6![ VVV6JAE4&H.O
M@G<&.;Z],* !QDV&CHB T!M@$[KAD$>B//0#*H)1+=K3^5EZR )(XL_[>_)
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MZ]9N<"^H+;YQO]Q+6.V6_P%02P,$%     @ 8D875V5^F^UY00  YFD!  H
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M=A9J6N5I7,QY1AZ%*+@Q/U?)2NWMK*7,X*V-S?OL7.>.43:6<<Q*1+>S,WR
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M3F*X+=<>:)8F"IS6'K1/N,QY.&>$_)$-<L*G$&A#( M1'"0!2V,<8( *CRZ
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MXMV.3;,6+7G@WQ81I8W$HLSD%>&/8HXT55,UU<#?\8+,TBPW_G"S(;6,E35
M-CR(7,IC\9*QW9*@CGMY; \/3K.9H@R/'6O-I!UH^ C<,9&@0DU*TP:M3EV)
M4G>U>,+GMV ]AR<B+UO&Z>D[4\43N_L0J^1ZG_M#>'YG<K"V.)U]=ZO\UW>W
M!L-?I5/];[[F>H,KI*UB?PO\X0(W07B]O0G,P),(;"5*@4?NR-Q'^$2QS$E!
M-E@ W(A7457^U7(7"%(,#5/4!WZ;:_%QH3&* !T/6N8Q9DO.@'$X?719&4T
MQ\\0GR3F23H<Q=N )"GB46(U:D_'BXH/""JP445<AT)2HD Z-@2M+" S-H/"
M8%4UB?(/*LI196$(% Z"N0"+#]FL9<R<"69+*L;/54J5"5#/LHS8[A7I&@L$
M=U.-:9' ]P1AG40K%4U+\:P)0G-&\6(8Y83R<A%] )4^08'J*4P+V+Z2I72!
MB_6DA.5)3X! 0@KXWA) ?8KH'S7N;YZ>". Q>CK)S_C8Z":,F/Q.$_G#FRG8
M:$#!KKX%L,F7>0Q+A+/!Q/0?*+ ##-485D0GMSO$VAJ&"H9&X5G+=<^XS(=:
MZ5(BHCX/ _XR%WCW;US@YWH>"XD68YWB6$X-PVT*M.<QT#/8I70)S)5#3;XB
M]:[;D8-%/5;,+B"HW\OL#_:1%V=XH^5 UFWXM9=YUV5VETI[W;N+_[JY\5\W
MH;+SG;?JB^SOY_;PO,ZP-#7+[$(S]HOX.TI+5 I >G(8&3"%-#L#?0SA#DQX
M3!*C\['ZP4@.HH 8H&"3(L.7)!C:AP934&I"D*$"'3RU.*>X( 1[I(MRX/F8
MANHE!=9$Z&,"<[ATCBBN1H$2RW-)D2(B54#(!76&6F8(0G"]!C#KNAW:ACQP
M0 :XWWD0HF#<&*>,#H:9HF X4&5R-/FUA1I<7AEG(5$(6#$'?9JJC9""9VUJ
M3V.*6JQA4W]*@/VA^BD[0[AN4%LFVJT)HNXCC/$+Q'T+VFLPFUX14Z&.$C5[
MV*9]T/,3]B"8:#]O2@9?&0/]FI=Z;@.[9;A7_'Z<%88+FF1&.@&&@L?:'05'
M0Q#$5G-VD0N0.7AM'TY"RM9(:K 6COIH<T!XL(( =S&I\$4I.@R&G\6G8)S,
MA- WP^11 09$:1(NFJZD>HB++8.RS/46K\4'B'"U\)J5^)5\/0TAH!S(AB:P
M3+)R'3CNA?IQ @07?>+Y3>@53',-.ALRF$:*IBB7W4XZW'FXJWKX!%T7^+SN
MWPVVQ'YJ !;:(2\]H+;ORNUWC!6C].^3/QS*2$@9<H^APO\'(+ 'S1@P5O##
M;/1O#MIQT-")7UX(N CL/.:'Y]'*(.YHO U <\Z68D@Z]P5#6P1S-E!W[R"-
MCZ/-/V5T:&(AY&XG YMBAMW[6[>VX<)"&K6#.I<>>LS9A9ZV<+:ACY2&AM\)
MS:0T?@/@1;A]RDJ.&H$66B^DPB$<5\TR YL\=BS>791<+]@T%4+$^D#+.?H"
MRGE.K@A>S[#UR C'-:($SAGE%:S152A*,9Z;PK0<:Z>=J6V(33.<M@":M3,+
MKE*5EGE5SL'V\06.>SMSKY)%@KR]02O."T.N @,H^+RNU^Y"D@AC55]M;7E(
M@23RU_EJ@#K-%K10:1%LNB%3N8H!L.Z%36]DD'U@(.18@MU+5NQ;FA@W@C<O
M&_,<U;Q>3Q2,.#=%R<AI0TE^).;0J#6>*4=J5 !TG&O,1<9HKQ2[;^%;"TMK
MX8Z04>-C[(A)U[UI;9ZT67QJ *VY)CF7ZS$G02\Q]G!6Q0D&?F=P03$"(X^J
M"8=^X[,DI,D3!@>-=2QI+6'DMCJ-,PG@9\? &)DE7-&X;%X0&^'A*73L@&M@
MYS +DHY^@("704&QA0[OL2(_C"C [:>!9:]("M*MPSE@EAPG 1;E$N4_J7])
M_%=DI($CO"VA>%'/-KL[ZMZ3<(K&A8$OR#!E1-1M85^67L[Q9= M:G%FK _*
M7^?+$+=<F64J9J@J^(ZG95]7=.(61KP1V:X/<'.I2)<,<#/,D(#QP&XXB-(8
MU+CW)"LD1"N(_0JQ= ;(ZS%?=4C]RD*\NIWFQY<(\3HJ)6P 'HS(M9N=I<"L
M0;EJVR^G*&'>%#L9K&+4[8A=:1)(Q6)CZRK89=E>V6R[*:U5%.Q(U_::7==Y
MW=;KS_K-IT>Z"A&*9SU0V9NEQ9T$BR4)K:Y[F;L<YSX_R?TH.),PYCS5:^K9
M8!0]RAW28Z2L9\NK#0( '"/)QLSO)+?)YK*[0*RF>HPA$Q*P!G*V)3 -'B!?
M5>MZ>QQU!^QBP/&<=(]IH54"FC059ATX8=T?A/$;D9J!-K>LUS,6Y&4V0TL
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M52UUU^GAP&2084A>N/IU(PU4?2W<6<7@QRL/XP5Z([P3G0C+JJ2E+:JR(NB
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M[:\&2_[R$?A_I_GGQF:?X=AU//CS-O^\]/;^;<+YB@>*UOB>Z1YXK&V<3@,
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MX7<#H/!>/BQ;QDA.*^PFU$NPV'<BG;HE9[;1*:V/'+;&@#D@R#=>@_UV@%H
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M9+P&Z@]!?I,)2R637'DLI*ZPG)BI]^$%5;HR<T2OIM12K^BK'MQ6RP+MQ_V
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MY7];ZU<0\Q+H'7A6$DM98$X"(W;'O(Y@'A3N.E\S#N/=AO4@ARK7C4LB:XF
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MUR(T-OU*&()G9A.=E$:S 8DBT+ K,;#_VO"U:/4QY3H@R:DOXE/565F,67
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M;&EDU,B@UMUL_/SM"+3E&#0"RI\$G6334ZCAK3YN$ ;.I^7+"*@;"[HA0=T
ME#([IRJ%>71(B%&#P2Q8A=,,(R17>XVC,;@;#S\&3;L.MEC;=DSLPAQR3!O)
MC)I4\R$D24:T""+X.]6Q[Q_%LYG,*@&>J<F)CI2_;F$VXKA.)M@=] DOH(6:
M#0 =TIZ)-I^&MP&@QY(=C'LCX#9F+0'HOXA@A6>.;1 6"RW>1, UV[-<9QA/
ML?\RTH Y[C1J>!@!PM0< <'OU#0]RTYIMBF@,IL *92+8!U^(O[/KDM=@Q1W
MT_(GO#6)BQ%'DB2_/7K_/5&V+9=8;O)\V -N:_*O[PF7#-RTU,$T;Y?VT>[^
M3S*)]BDQ]&W4).X.JF.3;*.!/MA!M8KXY2:CEF\NFO^HE8-2Z11^</)0,OG4
MUMF-&QC>362(-\$0GX$G5QJU>DGSC<T; M(%],/_JQ9P<%@&UCC8J%DZ&1R2
MX4T&_MG*Y?.YW'/P;H7PEDQBZ?"ONV_@SDT;&XP\ U5^#_A<N5%N?,,@<<*C
MY^!0;YI=[!!VH]X(.RB1,/'L.7@JG)93'U=VBJ29R%NV/D3,'1KD>Z(-XK>-
ME$S/1>?4!) ZZ:.&;6)K73Y8!P(<VA:"KM/[H)U.6<_ PVUDV181+^E@FTLL
M<;@JB+^HKA-+* ;_$P#KG@FX-"GS [?!+4>)G;2YK'!CQ37/@I$">D*W8R4@
M41R+P&XZ@O;E/45D(E$40A&+/!T9%N\+[!MQP.42)B&X&=UFPC]"IT@XO>VN
ML)&@7LE *U(#IB?\MR[8@>\)1LV>0:3N^SU%<<O>F.TY06< )J9XVQ\EHOK4
M* .[%( 2P=31T]%SJO,W;4H<)*@GL?ZF7#N,3L!DXW%WZ=C^_-YZP%);GZ8"
MG+[C5K!+BN,A!)C&[Z::P>S-:!2\F20K0D#PT&=CE+>>125C0:.FN&D2S#R'
M%'W5VP:8 %GP*MH%QS8#O]3CF5WX3!! +^YC;"^F^@'=AFF<YBUO*W0 N[83
M>OU\'DS2&(<UU&F%6+9)K<>Z?9POD_W&(0[>1[@PQ5!?*T,Z*"U"8/9VT] >
M?O+_[?8"4VEBIT.MI&OWMA'8V1WD/W!HI^M&'[5LU[5-\2P!:XA>\8TPL1ZV
MPA8_V<8F-<!ZS[7Y.TC ,OI I(O8 7MJV,XVVC.P=I<H_O<_2CZSLYOFZ,?D
MAGQ7PS-(\A1WA(L-NX]9(PF1O8/Z5'>[O.?,/XE(ZY;M ,-E:T$*RH'_8K9!
M]1WDOPPPR?=*:F,,$1[5*]@S-7X^^?Y_0SQ(1YCP=XM&[[G+CA'1XX%Q$YW$
M!NU8VT@#]T*<CQWLYO1@=UO%BWKMO%I976F>E\ZKS=UTJ_CWC+U9+5\T:N>U
M:G-UI52OH.I5^4>I?E!%Y9/CXUJS63NI+RI#U%B&_,*L2ZV.:UOKJRN55#F%
MU,Q&;NLI3%#_0"8LU;^X?](XA@&*#OA"BP=H6YF"B#N3R8JM>3R\X!'_C38*
MD<?!\L.@[YZ=[?7.[YD*^%X2PX3[2!0WDX>3 <QH,I9"^,<+8<Q@00C!"C>J
M]?/5E4;U]*1QOISIA9WI4\]A'K;<U177AE8:3_DB)8ML!RD;:_HW9+>1VR6+
MZG7CF0)\\!SJ4L)65ZH#K8LM6'*7-)<S0]G*YI;ZL+!3SW,\JRLPSPW2LQT@
M8M(39R8\\:G(_U1E=BC>)>_M72DMK9[_E;E[EDN6>S#?$W3@;NN W038KHZ'
M0X(=8L6Y[ @QB6+)ZWC,16IV'7&\2S^^N-(<OYB<%-X-7WAE0KQ!.I3QW3Z7
M;PK$R^[#0:Y5VBR<U-7\"Y>3<7V!:-9@E5L[/KZHGYQ7RS]0K5Y.O4(^_\0I
MBY'/M>H :^"+.?>XLW%&7$.8(=8C&L^-ZXC"I+H,@6=R@.QO?[7VNKAE$"#1
M,."Y)LH5,@GQ=P_K>O#WLQD22AF.,H% CH%[#,@+?I/)[UW7"3JX)XY+-6P$
MK .&!@GR75</H'SD6?6?.$:_JX.;- F;$9-0LS3; <<GMOZ;+GB1LMSR+MOZ
M# N1+U^IY0%IGBK/LQ A[\:K$OBNC$MZCGW/A3_JWIY 6Z)8(0;N@V-\BA5Q
M]9ES\M%3,B'4<RC["M)2B4C+/C4(L+E%G'C1*)7Z]K^=>N[RH?LJYS'NA^\9
M*DFUD"FHRWE^QWG.1>;Y' ]J_L:L)K1OWJ3_O*C30N90OVS<OFK29W2:*&ZH
MT"2WL:D^503@/\[+[/1'SL*:,( 0>$LJ;(BZ'70+<2C3J0C+Y\K.%Q/E#V5<
MV39-RMB21;-95$LU4LT4JIH]PQX2Y\_3#E@,T[#___9E>/O%IIK[2B1-Y9)'
M,\B)^A5)2MU.?8M7B[2(,(K+N.HSXZJGQ_E/LUU/Q^<3G-N:NRH;+YVV(DNG
MDJX[A#'_QQ&UB!*_;+H^^;>KGEW=ZGPM]/HYEJNZEZ^^8NA.%%5%*4A.-G^A
M'R"M?3Q$N<VI\LGP JSU9F*;**Y/96.K<<PNPZ\GSKG=MV:$)9YIJ16U6O%>
MM4"=ZBU1/ &YPW'UGMR,^.HU7J).+[L+<<,1H>Z)<PJA,;C &5&X2IQ[?#JP
M+B_?2'I>S9<)LL$S'<U=K\<YA6=KZ2>$3H'U?"3L?#^#LQ$G-*<VA!/&->W-
M3MPHF5L]\ZO;J0_I%[(X$<(3Q6PN5XC9N/@C SQ_A,AN2SIZ#B@&[6$#D0'1
M/)?>\Z0O+$L(6R[=9C$1) -QT5@NUK[0?LAX=^>__]E4E<(.6UUQB4%Z7=LB
MR!+1R#H/X R/KQP1=@B&<>DP1C ::Y,6+>];-.Y:2P ZVX8-<MJF>U3-_JB]
M--D4[@/,S<;<I%*K^&VZ-BO8$3ZRP=R<\A'/2X^YSO$I,P_V*K_U%U(\V4^B
MF,MM)@N%K<)<__HW[@V]M5K<>@SBQN&GC[;<)=H=J%B7(-SK.39X$IX[;-D#
MU"*&W4=45.V@?=LQT6;R$+6IP?6.,E!"EU@ZT<$A(D9-SW"Q16R/&4/$(!QF
M[:%HZ3>P6S!P$27[A4#A+4D/\#BK*]@:!B_;$+[9?=Z0;^10GI)C:(T1@@Z(
M11SP=#4+&GNRS*B44E.2WF_;[[&%^25%\FN%U<_:KLRDU UJQ6K$AVY.E'R#
M^\NA+@@S3_]ZEI_,8?%6M]VY:*CYC:Y7SKZX!*=EVP;!ECC3%[;'L63PZ=\J
MY'([+]VF^E F^T. I^$Q^*M4OT*0&PQ^  7EU VI^D+EQ[5RHD)N32F@\GX#
M >-3 #ACE?::9?J[,^.9*]Y/H.</8>2<:H.F;5 -I,;J'(/C N]EQ.OMUKW=
M.]NX5F\;N3?7VVD:_BRE'=,OZ3#]44QKK)+#244-*6VDJ'6DLKE,2D(NM7:I
MM6&M57RM/74(]W+\(+DX(,(7DLY)NSTKUKG\<=^Q&UV-GKRY\LXFY<]28AA'
M4@L-1%(3]<-Q"JTGU;76MZ>IM(1=*O52J>-*?"8TJ<:81YQ'55LI.%L_\1V]
MW=A\;]V>HNBOT/ L2>;6M*=IN _[X2G1KY(.^;N2/S5+YW)#5E=:0Z3Q3!#O
M_@[UNT34C$UD:2A#0 :('J>P@SJ.W7>[7/YZ/'&#&=))FUJRJ#SZEXSV,AM!
M=F<BU).'H;*K*VN<_X4=$?(%T%14I_=X=3H_2R9E6FTEU1AD<4>L4("4R_>X
M70AMZKVKWK_*?/]=TEWU!75U94)2'ZU&#EH>B'9EV2S>>V7.U,M+PSE\L.B;
M>Z\YQ#S+<2VE>H&DNM;F>?)95IAOC4F;CJ(FG4[EW+M@HHE!-!=,M&6+]8+'
MB(""8?N9?7Z!(Q4I=GD[%9=;T9<Q%)K5I] WURD+A@.O'')/&30$RX\MC:<0
ML":N.N2D\NLS=>SH3.;T>0?AU<KXS/ :#DX+1RQZ"HDB"5_NEP+^/ANU+>@3
MA I6BTF?C'Z7NN33N1 ^2BW%F#BS)$A$M+X$@>"\RYY0'._$,]! PK&JA90X
M2_E5&?J5=Y6F(ZV)*[1:TU=H30;+$C1^HH(#,KE_WH^_Y_RV5?\(1AL1K(&5
M-C!C<P/*F(A_[@C4=QS $W(F[S(KRN9[SHJ#]5&BNSDT6[:QG)!')B3WGFK"
M3W%'M80$/A],.9A*>#*V][,R9H]/W.QQOF.R;"+,4(--*^G+AA"/"BL1'UO\
MN&M>.?NUFLF4%Q;X3/:3*/)T6'!0H>G:VMTZZF$'W6/#(^A_,ZE,1N%+/20N
MKYP97+Q>7SY52;ZB:)1]T?#MD[1,\7)Q:"N_]?OS'YE:^X5R$>E$7*&PG.J/
MF^K]"2L0Q#BS[\XXOMXS^V[E=_.^\*J3\=RR3A^*CZ,#[/*_S:ID9TETA*TG
MR,@R5_P9-\U&_'OL7;.ANVC#H_K<FV8_J6YTT0L#HT+(6;\#Z'Y[?-L(T,AY
M$&9R6JCFW%#\F-#FQ4#'X6,X7)P,)Z.=3L>!$_'B]/F0N5ND4?$P2%NTF+H<
M(?O/F('<=$U#Y!Z%F,3!S5]@^H*;MZ=8[1!\EVP1,,XPH)Z8GS!S\S.EZ ]@
M[KRP3EBR)W$K;$#FVHZ7)+V^HLXNPL F#V@*4=")YI^SWY8;T/SC0(EBS27F
MZDHAE5%2J$$ZGB$KP_<KJ$*99MC\JOS4,_8R7IS\#))UF90H2%Y8V8A=0'U!
M#IQ ;.I?-NC?-0@(B(XJ*70(=L[BH:G7,GF1L3AX *$+JHD/!)T3K8MJEI9"
M:SSMRX\/J9D=?[],_*7L?$.8)XSY?8QRUX-J) )>%X\"Z/75%7Y;HHY\BG(!
M18R0.[ZC 03XWVW@&R<. >.,+9WR1DP<B^ ['F+/1.RT<!&'I[R_$%W\D!/:
ML[&C\PQ(A3H :3LL0I=X'9"UNH+=6"3B$TO8LCQL(%CDBTT70,EXG-^U#="^
M*%8!7Y+PQQ(^Z".%S@%.4L5WBOC&#NESGL-CR26^#Z4CG8"--\5&O]L%NJB+
MVI@:8OARHPC)3:)>SP!7PAV8PS\ZY8@2%B:88V+!3=T?>L!34<\BD&*' ,]=
M#@RHJ!4W>E[$8. ^2Z$3"TW<5[D>RR[;<QG5"3BQ#C" ;U,Q8D __(X\> @B
MYD38=20>C40)!GCLC,1R3$: -D (D]XB76RT@QT)GPXN'6**Q!#'?$6Z#=+#
MM^0@M --=3V0+LQ3-'0DLX IEEN<FQP3'S0H4F1JUQ&?+\P$@$ZPSDVQ:"&W
MX\1Q.N2"ML*<<5!^'(@XH2[#/?DDQXB0D)<>9HSHO,OAZLK4?/HZR%G8(C#]
MP*WP/DZ(%WUJ&!Q&I\R!:8(EC9Y")>!,;W142$X+KTYI>XY%69>(458'7=H"
M:=S:2BF E)]Q A!Y&>O'57Q\01.[=#(A)Q-K(4"6F,>E"%2 '[-VP'IC1KAI
M!9W6XG16G(<3*CHIGE$4$U+*;X4>B:DJ9?_I4KK(<[244G# JRO4&GT_4V3Z
M<%!2QU?0B"^@)X1&6&Y?J)@T?OR)$"_LNECC@M<E#H%FT,AW;2.9]+V;:,/
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M0*\SWMF/K5;Z;.\ NS^;_>_?)4O^'U!+ 0(4 Q0    ( &)&%U?[GK$F)@,
M .,+   0              "  0    !A:6TM,C R,S X,C,N>'-D4$L! A0#
M%     @ 8D875QG2%A?]"@  @(8  !0              ( !5 ,  &%I;2TR
M,#(S,#@R,U]L86(N>&UL4$L! A0#%     @ 8D875U:=>5-5!P  UE<  !0
M             ( !@PX  &%I;2TR,#(S,#@R,U]P<F4N>&UL4$L! A0#%
M  @ 8D875V5^F^UY00  YFD!  H              ( !"A8  &5X.3DM,2YH
M=&U02P$"% ,4    " !B1A=7?MU*!7 8   ->0  "@              @ &K
M5P  97@Y.2TR+FAT;5!+ 0(4 Q0    ( &)&%U=S4>[KCA0  /"A   +
M          "  4-P  !F;W)M."UK+FAT;5!+!08     !@ & &L!  #ZA
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
